Seguir
Sverre J Mork
Sverre J Mork
Professor (emeritus) of Pathology, University of Bergen, Norway
Dirección de correo verificada de uib.no
Título
Citado por
Citado por
Año
Axonal transection in the lesions of multiple sclerosis
BD Trapp, J Peterson, RM Ransohoff, R Rudick, S Mörk, L Bö
New England Journal of Medicine 338 (5), 278-285, 1998
50451998
Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions
JW Peterson, L Bö, S Mörk, A Chang, BD Trapp
Annals of Neurology: Official Journal of the American Neurological …, 2001
17052001
Subpial demyelination in the cerebral cortex of multiple sclerosis patients
L Bø, CA Vedeler, HI Nyland, BD Trapp, SJ Mørk
Journal of Neuropathology & Experimental Neurology 62 (7), 723-732, 2003
8672003
Neurological disability correlates with spinal cord axonal loss and reduced N‐acetyl aspartate in chronic multiple sclerosis patients
C Bjartmar, G Kidd, S Mörk, R Rudick, BD Trapp
Annals of neurology 48 (6), 893-901, 2000
7332000
Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration
L Bø, CA Vedeler, H Nyland, BD Trapp, SJ Mørk
Multiple Sclerosis Journal 9 (4), 323-331, 2003
5932003
Ependymoma. A follow‐up study of 101 cases
SJ Mørk, AC Løken
Cancer 40 (2), 907-915, 1977
4591977
Class III β‐tubulin in human development and cancer
CD Katsetos, MM Herman, SJ Mörk
Cell motility and the cytoskeleton 55 (2), 77-96, 2003
3752003
Pathogenesis of tissue injury in MS lesions
BD Trapp, L Bö, S Mörk, A Chang
Journal of neuroimmunology 98 (1), 49-56, 1999
3681999
Detection of MHC class II-antigens on macrophages and microglia, but not on astrocytes and endothelia in active multiple sclerosis lesions
L Bö, S Mörk, PA Kong, H Nyland, CA Pardo, BD Trapp
Journal of neuroimmunology 51 (2), 135-146, 1994
3381994
Class III β-tubulin isotype: a key cytoskeletal protein at the crossroads of developmental neurobiology and tumor neuropathology
CD Katsetos, A Legido, E Perentes, SJ Mörk
Journal of child neurology 18 (12), 851-866, 2003
3052003
Oligodendroglioma: incidence and biological behavior in a defined population
SJ Mørk, KF Lindegaard, TB Halvorsen, EH Lehmann, T Solgaard, ...
Journal of neurosurgery 63 (6), 881-889, 1985
2961985
Fish protein hydrolysate reduces plasma total cholesterol, increases the proportion of HDL cholesterol, and lowers acyl-CoA: cholesterol acyltransferase activity in liver of …
H Wergedahl, OA Gudbrandsen, Z Muna, RK Berge, B Liaset, E Lied, ...
The Journal of nutrition 134 (6), 1320-1327, 2004
2952004
Primary intraspinal neoplasms in Norway, 1955 to 1986: a population-based survey of 467 patients
A Helseth, SJ Mørk
Journal of neurosurgery 71 (6), 842-845, 1989
2821989
Expression of oligodendrocyte progenitor cell antigens by gliomas: implications for the histogenesis of brain tumors
Y Shoshan, A Nishiyama, A Chang, S Mörk, GH Barnett, JK Cowell, ...
Proceedings of the National Academy of Sciences 96 (18), 10361-10366, 1999
2361999
Reactive microglia in multiple sclerosis lesions have an increased expression of receptors for the Fc part of IgG
E Ulvestad, K Williams, C Vedeler, J Antel, H Nyland, S Mørk, R Matre
Journal of the neurological sciences 121 (2), 125-131, 1994
2051994
Grey matter pathology in multiple sclerosis
L Bö, JJG Geurts, SJ Mörk, P Van Der Valk
Acta Neurologica Scandinavica 113, 48-50, 2006
1972006
Distribution of immunoglobulin superfamily members ICAM-1,-2,-3, and the β2 integrin LFA-1 in multiple sclerosis lesions
L Bö, JW Peterson, S Mørk, PA Hoffman, WM Gallatin, RM Ransohoff, ...
Journal of Neuropathology & Experimental Neurology 55 (10), 1060-1072, 1996
1911996
Panel review of anaplastic oligodendroglioma from European Organization For Research and Treatment of Cancer Trial 26951: assessment of consensus in diagnosis, influence of 1p …
JM Kros, T Gorlia, MC Kouwenhoven, PP Zheng, VP Collins, ...
Journal of Neuropathology & Experimental Neurology 66 (6), 545-551, 2007
1842007
Neoplasms of the central nervous system in Norway: IV. A population‐based epidemiological study of meningiomas
ARE HELSETH, SJ MØRK, A JOHANSEN, S TRETLI
Apmis 97 (7‐12), 646-654, 1989
157*1989
EGFR wild-type amplification and activation promote invasion and development of glioblastoma independent of angiogenesis
KM Talasila, A Soentgerath, P Euskirchen, GV Rosland, J Wang, ...
Acta neuropathologica 125, 683-698, 2013
1552013
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20